<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by D on Medium]]></title>
        <description><![CDATA[Stories by D on Medium]]></description>
        <link>https://medium.com/@Yi-Jung?source=rss-131691031a66------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*AydHlEIiZPaQ6Oa-tXR3Jw@2x.jpeg</url>
            <title>Stories by D on Medium</title>
            <link>https://medium.com/@Yi-Jung?source=rss-131691031a66------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 21:37:21 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@Yi-Jung/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[《投資心得回顧 — 2025.10》]]></title>
            <link>https://medium.com/@Yi-Jung/%E6%8A%95%E8%B3%87%E5%BF%83%E5%BE%97%E5%9B%9E%E9%A1%A7-2025-10-118b87ac7669?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/118b87ac7669</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sat, 18 Oct 2025 10:26:28 GMT</pubDate>
            <atom:updated>2025-10-18T11:08:15.126Z</atom:updated>
            <content:encoded><![CDATA[<h3>《投資心得回顧 — 2025.10》</h3><p>過去一年半在投資領域的實踐中，我開始嘗試將「主題導向尋案」落地化。</p><p>本文記錄我在案源開發(Deal Sourcing)上的思考與學習過程，希望藉由整理經驗，持續優化自己的投資框架與行動策略。</p><p>前期案源開發目前約佔我整體工作時間的5%(我每日皆有追蹤時間分配)，我大多時間仍在投資評估、與投後管理上。<strong>因此相較於廣撒式尋案，我採取更貼近自身優勢的「精準打擊型」策略</strong> — — <strong>聚焦在每個投資案中，主動延伸產業的上下游潛在投資機會。</strong></p><p><strong>我透過主動聯繫與cold mail開發約20家潛在標的，涵蓋領域包含RISC-V、資安、AIoT、人力平台、感測器等。</strong></p><blockquote><strong><em>(1) 主動尋案與議題導向觀察</em></strong></blockquote><p>在過去一年半中，我逐步建立主題式尋案的思維與行動模式：</p><ul><li><strong>義大利資安新創</strong>：<br> 因上半年參與資安產業投資案，我開始聚焦追蹤全球新興資安新創。除主動與 Palo Alto Networks 台灣業務經理建立聯繫外，也 Cold Mail 多家台灣資安公司並拜訪。後續從新聞稿<strong>注意到一義大利資安新創與聯發科發布合作，考量台灣在工業電腦領域的全球優勢及AIoT長期之發展潛力，我主動cold mail其CEO並安排線上會議。會後發現該公司2024年營收約€5M，且2025年預計可成長超過四倍，遂與亞洲業務Head建立長期聯繫，持續追蹤公司動態。</strong></li><li><strong>美國半導體製程優化軟體新創</strong>：<br> 因曾於Micron任職，對製程優化領域有長期關注。<strong>自2022年起持續追蹤全球前大三記憶體大廠旗下之新創投資，並於2025年Semicon展前主動蒐集參展名單、建立約10家拜訪清單。當天現場與美國總經理交流一小時後，展開投資DD。</strong>雖因突發因素暫停募資而未成案，但我仍協助公司對接台灣潛在合作夥伴，持續創造價值連結。</li></ul><p><strong>(2) 持續關係經營與案源維護</strong></p><ul><li><strong>台灣大型人力平台公司</strong>：<br> 看好亞洲區域的人才媒合及人力搜尋趨勢，持續與團隊保持聯繫並定期追蹤其產品及成長動態，視為中期潛力投資標的。</li></ul><p><strong>(3) 大型私募案開發</strong></p><ul><li>在評估傳產同業期間，我主動開發並推進一家<strong>傳產上市公司的大型私募案</strong>。</li><li>該公司年營收約40億元，此次併購若順利完成，整體營收可望提升至100億元。本次私募規模約新台幣5億元，目前僅任職之投資機構與另一大型法人機構參與評估。</li></ul><p><strong>(4) 綜合反思與下一階段計畫</strong></p><p>回顧這一年半的案源經驗，我的最大收穫在於理解 — —</p><blockquote><strong>優質案源不在資料庫裡，而在產業現場、新聞脈絡與人脈邊界的交集點。</strong></blockquote><p>我從「等待案源」轉向「主動創造投資機會」，並逐步建立以議題為核心的探索習慣。</p><blockquote><strong>在持續累積一定產業知識與人脈後，我的下一階段目標是將主題導向深化為領域專精（Sector deep dive），鎖定七大方向持續追蹤與拓展：</strong></blockquote><ol><li><strong>資安產業（Cybersecurity）：關注 Edge 資安、身分驗證、與工控資安應用；</strong></li><li><strong>工業電腦（Industrial PC）：觀察AIoT化、垂直應用場域與供應鏈轉型；</strong></li><li><strong>RISC-V IP 生態系：聚焦開源架構在 AI、邊緣運算領域的導入與國產化機會；</strong></li><li><strong>感測器與邊緣設備（Sensors &amp; Edge Devices）：從 AI 影像、溫控、環境監測等應用切入；</strong></li><li><strong>存儲相關（Storage）：延伸既有案源，如Storage Controller、NVMe 解決方案；</strong></li><li><strong>半導體中前段設備 （Semiconductor Machine）：延伸既有案源，如 RF 測試、ABF載板與半導體製程設備相關；</strong></li><li><strong>人力招募與數位平台（Recruiting &amp; HR Tech）：關注亞洲市場平台化趨勢與 AI 招募技術的應用潛力。</strong></li></ol><blockquote><strong>透過在上述七大主題下的持續追蹤與聯繫，我希望能逐步建立起跨產業的投資網絡，</strong><br><strong> 最終形成「主題式觀察 → 案源識別 → 產業連結 → 投資實踐」的閉環，<br> 讓 <em>Deal Sourcing</em> 不再是個別動作，而成為長期、可複製的投資能力。</strong></blockquote><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=118b87ac7669" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[《投資心得回顧 — 2025.7》]]></title>
            <link>https://medium.com/@Yi-Jung/%E8%BF%91%E6%9C%9F%E6%8A%95%E8%B3%87%E5%8F%8D%E6%80%9D%E5%BF%83%E5%BE%97-2025%E5%B9%B47%E6%9C%88-3bfc2d0672e8?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/3bfc2d0672e8</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sat, 02 Aug 2025 08:16:16 GMT</pubDate>
            <atom:updated>2025-10-18T10:41:12.239Z</atom:updated>
            <content:encoded><![CDATA[<p>以下為近期工作觀察與個人反思，僅代表個人學習心得，不涉特定公司或個案內容。</p><blockquote><strong>1. 投資「信任的團隊」比什麼都重要。</strong></blockquote><ul><li><strong>Due Diligence 延伸至中階員工</strong>：聚焦在<strong>任職3–5年</strong>的中堅員工，往往較能反映真實企業文化與管理風格，避免資深管理團隊擅長修飾與美化。</li><li>留意會議中的<strong>決策機制、發言分布、上下層互動是否自然</strong>。</li><li><strong>進一步單獨訪談非CEO成員</strong>，如CFO、HR等，探測有無潛在<strong>派系與治理風險</strong>。</li><li><strong>回顧案例</strong>：如某家族企業案，雖與總經理溝通順暢，但透過觀察與單獨訪談，發現潛藏多年的內部權力鬥爭問題。</li></ul><blockquote><strong>2. 買方競價對併購出場至關重要 — 出場價值不僅靠財報與營運，更仰賴市場塑造與競價管理。</strong></blockquote><p>這一年有幸參與潛在併購案之討論，幾個要點關注:</p><ul><li>第一是以各方角度去分析各方案的優缺點，管理團隊、不同賣方、各股東間等的角度都去衡量。</li><li>第二是，交易溝通方的利益與股東間是否達到最大程度的一致性。</li><li>第三是，促成潛在買方的競爭性，適度釋放訊息。</li><li>第四是，時效性為併購最重要的要素。</li></ul><blockquote><strong>3. Term Sheet 條款決定未來勝負。</strong></blockquote><p>包含資訊權與Liquidation Preference，特別是在併購發生或公司狀況變差時，都會有重大影響性。</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3bfc2d0672e8" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[億豐:  OEM 代工轉型客製化，25年長期價值思維的體現]]></title>
            <link>https://medium.com/@Yi-Jung/%E5%84%84%E8%B1%90-oem-%E4%BB%A3%E5%B7%A5%E8%BD%89%E5%9E%8B%E5%AE%A2%E8%A3%BD%E5%8C%96-25%E5%B9%B4%E9%95%B7%E6%9C%9F%E5%83%B9%E5%80%BC%E6%80%9D%E7%B6%AD%E7%9A%84%E9%AB%94%E7%8F%BE-b8a4bf1f1660?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/b8a4bf1f1660</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sun, 06 Jul 2025 08:46:04 GMT</pubDate>
            <atom:updated>2025-07-06T15:22:50.603Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Iap1eR6WJFZNFCh0XWmRCw.png" /></figure><blockquote>在快速變動、短期績效導向的產業競爭中，少有企業能堅持走一條「困難但正確的路」。億豐(Nien Made)，就是這樣一家少數企業。</blockquote><blockquote><strong>一、從穩定代工，到經營困難但高價值的客製化市場</strong></blockquote><p>2001 年，億豐開始從原先穩定的窗簾 OEM 代工業務轉型，切入<strong>客製化百葉窗市場(Custom-Made Shutter)</strong>。</p><p>別以為這只是產品升級，<strong>背後是完全不同的商業模式</strong>：</p><ul><li>OEM：只需對接 Walmart、Home Depot 等大型通路商，標準產品、大批量出貨；(訂單約3–4年一簽，穩定度高)</li><li>客製化：面對的是一家家分散的地區經銷商、小型設計師，必須<strong>逐家經營，逐窗訂製。</strong></li></ul><p>這條路不僅市場碎片、經營複雜，且客戶忠誠度、品牌力、製造靈活度缺一不可。<br>但也因為困難，才造就了億豐今日的<strong>高毛利、高門檻、穩定成長</strong>。</p><blockquote><strong>二、財務數據</strong></blockquote><p><strong>回頭看億豐 2011–2015 年固定尺寸產品依然成長快速，CAGR 高達 +11%；但時至今日，2020–2024 年固定尺寸營收已呈衰退，CAGR -6%，可看出億豐經營團隊之長期策略正確與堅持。</strong></p><p>相反，客製化市場 2011 年起 CAGR +9%，目前億豐客製化營收占比已由 2011 年的 40%，提升至 2024 年約 70%，成為億豐核心業務。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/603/1*d8hoB3Ai7RHgiloYCvRKSA.png" /><figcaption>億豐年報 (2015年)</figcaption></figure><p>而整體來看，億豐：</p><ul><li><strong>近十年營收 CAGR +5.9%，惟 2022–2023年 受 COVID 影響外，無一年衰退；</strong></li><li><strong>稅後淨利十年 CAGR +10.3%，獲利成長優異；</strong></li><li><strong>毛利率穩定提升，十年間從 48% 提升至 57%，近五年維持穩定。</strong></li></ul><blockquote><strong>三、垂直整合 + 自有品牌，打造競爭護城河</strong></blockquote><p>億豐的客製化百葉窗，是典型的「<strong>1 窗 1 訂單</strong>」：終端客戶下單時，先提供設計圖，工廠再依照其需求裁切、噴漆、組裝、出貨，完全客製。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/777/1*T51xI2Nzb8R4V0hQxpJKow.png" /><figcaption>百葉窗之種類多樣、極高度客製化</figcaption></figure><ul><li>2015 年，億豐透過北美 11 個 Regional Business Center（RBC），直接服務 <strong>3,700 家小型窗飾店與設計師</strong>；</li><li>到 2024 年，這數字已擴大至 <strong>4,500 家</strong>，形成穩固的客戶網絡。</li></ul><p>產品價值更是天壤之別：</p><ul><li>固定尺寸窗簾：每窗約 US$15~100；推估毛利率約20%。</li><li>客製化百葉窗：每窗可高達 <strong>US$1,200</strong>，單價差距<strong>達 50~80倍；推估毛利率約70%。</strong></li></ul><p>這不僅是單價的提升，更是從「製造商」轉為「解決方案提供者」的躍升，而億豐也持續往上下游擴增、垂直整合，包含自行研發並設計裁切機，提供予大型通路商，並向下發展品牌通路、甚至自家之物流，目前已具自有品牌NORMAN® 和 VENETA®。</p><blockquote><strong>四、家族企業的長期心法：Ownership</strong></blockquote><blockquote>在倫敦商學院的價值投資課程中，教授曾指出：<br> <strong>「家族企業，往往比純粹由專業經理人經營的公司，更具長期視野。」</strong></blockquote><p>當時的我心存疑惑，認為家族企業可能效率不佳、內部治理問題多。但現在，我開始理解，<strong>關鍵在於 Ownership 與經營責任的綁定</strong> — — <br>唯有當經營者把公司視為自己的長期事業，才會不斷投入、堅持正確但困難的方向。</p><p>億豐正是這樣的例子：</p><p>董事長粘耿豪、總經理粘肇紘、副總經理粘凱隆，三兄弟攜手經營十年間持股從<strong> 28.86% 提升至 29.1%</strong>，未曾稀釋，展現對企業長期價值的信心。</p><p>在台灣二代接班中，億豐三兄弟是少數能夠彼此信任、共同推動長期策略的成功案例。</p><blockquote><strong>五、結語：困難，但值得走的路</strong></blockquote><p>短期來看，億豐可能可以靠 OEM 穩穩賺錢，但長期來看，只有客製化、高毛利、自有品牌，才能走出全球競爭的紅海。</p><blockquote>25 年前開始的轉型，如今已經開花結果。<br><strong>這是億豐的選擇，也是一家台灣家族企業，展現長期思維的典範。</strong></blockquote><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b8a4bf1f1660" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[《產業概況分析 — 先進封裝概況》]]></title>
            <link>https://medium.com/@Yi-Jung/%E5%85%88%E9%80%B2%E5%B0%81%E8%A3%9D-%E5%A4%A7%E7%99%BD%E8%A9%B1-5f58a3fd1512?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/5f58a3fd1512</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Tue, 13 May 2025 11:09:01 GMT</pubDate>
            <atom:updated>2025-10-18T10:43:08.016Z</atom:updated>
            <content:encoded><![CDATA[<p>前陣子CoWoS, 2.5D, 3D, RDL, Interposer, TSV等專業術語滿天飛，由於覺得很想弄懂到底每個的意思是甚麼，因此整理了此篇文章供參考。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*xNBlFaTNcyjGaw_AsZMMTA.png" /></figure><blockquote><strong>1. 何謂先進封裝: 大到小的轉換</strong></blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*wO2em8gc2Hj7Xth826jITA.png" /><figcaption>資料來源: keysight</figcaption></figure><p>用一句話簡單描述先進封裝的意義就是，大到小的轉換；</p><p>如上圖，下層是PCB，上層是矽晶片，矽晶片線寬現在的單位已經是μ以下，而下層的PCB/封裝基板線寬還是在cm等級，這時候這兩者線寬間的嫁接就是先進封裝的重點，<strong>如何精密地將上層矽晶片的極細I/O連接到底層PCB的粗大銅線。</strong></p><blockquote>2. <strong>先進封裝指的是2.5D以上的封裝技術，D等於Die(晶粒)! 不是Dimension…</strong></blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/966/1*wmPKwPmcfGS0TFiT6o1yiQ.png" /><figcaption>資料來源: 工研院產科國際所</figcaption></figure><p>很多人不懂裝懂就會講3D封裝就是立體，這樣的說法很大的錯誤，<strong>而且2.5D如何解釋? 你這輩子聽過有2.5D的形狀嗎…</strong></p><p>真正的3D封裝是指3顆Die的堆疊，2.5D則是因為中間原先的Interposer用Si作為中介層(TSV:矽穿孔)，而非真的晶片使用。</p><p>以下簡介四種封裝技術的演進:<strong> (主要就是因為晶片效能不斷提升，所需I/O大幅增加，從原先數千至數億…)</strong></p><ul><li><strong>1980–2010年:</strong> <strong>打線封裝(Wire Bond)，</strong>最早期、最廣泛使用的封裝技術，晶片Die坐在封裝底座上，用金線或銅線把Die打線到封裝基板上。</li></ul><figure><img alt="" src="https://cdn-images-1.medium.com/max/835/1*X6ViWP3Ur5Zmnt1ftogJHw.png" /><figcaption>資料來源: Semi Engineering</figcaption></figure><ul><li><strong>2010年~: 扇出型封裝(Fan-Out Packaging），由於I/O數量增加太多，原先打線打在Die下面即可，現在需要打線到扇出去</strong>，就是Fan-Out Packaging。</li></ul><p>(Freescale &amp; Infineon為全球第一個發布Fan-Out Packaging)</p><ul><li><strong>2018年: 2.5D即是台積電的CoWoS(Chip on Wafer on Substrate)<br>，由於HPC時代之I/O數量提高到萬級以上，因此台積電在中間多加一層 Wafer當成Substrate，可以想像成一個高密度拉線平台，而這就是CoW (Chip on Wafer)。 </strong>這段目前只有台積電能做，因為只有台積電具有設備能做到這麼小的線寬；WoS則將晶圓再貼到傳統封裝基板，這些就是傳統封裝廠日月光、Amkor的生意，這段台積電不做。</li><li><strong>2021年: 3D封裝，直接把Die都垂直堆疊，利用TSV(Through-Silicon Via)，可直接省略拉線的過程。</strong></li></ul><blockquote><strong>3. 拉線越長，衰減越多; 線寬越窄，技術越高；3D封裝成本極高</strong></blockquote><p>RDL線寬如果能做到2µ*2µ (目前只有台積電可以)就有高技術門檻；能把原本三層RDL整合至單層完成設計與傳輸，技術含量也很高。</p><p>一位半導體資深人員曾說，<strong><em>台積電3D封裝良率沒有9成也會賠死，因為現在先進製程，SoC 4顆+ HBM 6顆，Bonding壞了就2,500美金起跳。</em></strong></p><blockquote><strong>4. AMD &amp; NVIDIA</strong></blockquote><p>AMD Ryzen 7 5800X3D 和 AMD Ryzen 7 9800X3D要用到3D封裝，NVIDIA 的 Blackwell GPU（如B100）採用的是台積電的 CoWoS-L 技術，進行2.5D整合，不須用到3D封裝。</p><p>同樣是萬級 I/O 的設計，NVIDIA 靠的是單層大 Die 的設計實力，而 AMD 則需藉助 3D 堆疊來補強效能，高下立判…</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5f58a3fd1512" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[《價值體悟— 2025.5》]]></title>
            <link>https://medium.com/@Yi-Jung/may-2025-takeaway-5a0a851c48ff?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/5a0a851c48ff</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sun, 11 May 2025 15:11:39 GMT</pubDate>
            <atom:updated>2025-10-18T10:44:19.546Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*R-SZ34lK0C2Ciw20qvbpGw.png" /></figure><p>從幾次深刻的對話與反思中，我整理出三個讓我印象深刻的洞察，關於成長、選擇與信任。</p><blockquote><strong>1. 持續輸出，是整理思緒的開始</strong></blockquote><p>與一位資深投資人的 coffee chat 中，我受到很大啟發。他曾成功投資一家初創公司，在一年多內退出、實現 16x 報酬。但比起他的績效，我更佩服的是他對趨勢的思考方式。</p><p>我們聊到 AI Coding 的熱潮，他反問：「如果 AI 幫你寫了 code，那誰來驗證這些 code 的穩定性？未來是否會出現一個『驗證 AI 工具本身』的市場？」這種跳脫主流、反向思考的能力來自他每天「整理思緒、輸出觀點」的習慣。</p><p>除此之外，我也跟他聊了最近研究的投資案，為Thermal Sensor的技術，我最近探討此案的關鍵為，中階解析度如60*80~120*160之市場是否存在? 因為是個相對早期的案子，過去主要市場應用都在高階如百萬畫素市場，或是低階1~16*16等，是否有個市場是適合中階應用? 以及中國廠商的興起可能；我們進一步討論，這種to C消費型產品，其實你只做一個feature，重點會在你是否為”Key Feature”，白話文就是終端品牌廠會主打的slogan，如果不是，代表你這個feature是minor，那市場推動是否會遇到高阻礙? 如真的成了Key Feature，未來會不會成為標配?</p><blockquote><strong>2. 你的人生英雄，決定了你會成為誰</strong></blockquote><p><strong>Warren Buffett 曾說：「It’s very important who your heroes are in life. You tell me who your heroes are, and I’ll tell you how you’ll turn out.」</strong></p><p>這句話讓我想起一個問題：「我現在的人生榜樣是誰？」</p><p>我從小就習慣觀察他人優點。小學時，我會觀察誰國文好、誰數學強、誰躲避球厲害；國中時，我發現有個同學籃球打得很出色，於是每天早上五點半就跟著他去操場練球。對我來說，把事情分類、找出各領域最優的人、然後學習他們，是一種自然的成長方式。但這些都是「分項目」的學習，我總是找出每個領域最強的人，然後模仿、吸收，回頭看，我卻從未真正定義過，自己「整體想成為什麼樣的人」。</p><p>這些年我受到許多長輩的幫助，他們的言行逐漸塑造了我對於專業、原則與格局的理解。人生不是一次選擇出一個完美榜樣，而是從每段關係中逐漸拼湊出我們想成為的樣子，也希望自己有日能找到這個General的Role Model.</p><blockquote><strong>3. 信任，是人生最核心的資產</strong></blockquote><p><strong>Warren Buffett 還說過另一句話：「Lose money for the firm and I will be understanding. Lose a shred of reputation for the firm, and I will be ruthless.」</strong></p><p>金融業是建立在信任之上的產業。而讓人信任的方式，從來不是話術或表現，而是你在一次次選擇中，是否堅持原則、不違背底線。</p><p>說到底，讓他人信任你的產品、判斷與建議的根本，是你是否成為一個<em>值得信賴的人</em>。</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=5a0a851c48ff" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[London Business School — Value Investing Course, Takeaway]]></title>
            <link>https://medium.com/@Yi-Jung/lbs-value-investing-course-takeaway-603276640e63?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/603276640e63</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sat, 09 Nov 2024 09:44:57 GMT</pubDate>
            <atom:updated>2024-11-09T09:53:54.090Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/861/1*F4fvNjOgJVGmsQGdi7CLZQ.png" /></figure><ul><li><strong>Short Intro:</strong></li></ul><p>The LBS Value Investing Course is a highly selective elective, with only 25–30 students chosen each year. The course has a demanding workload, requiring at least 20 hours of commitment per week. It is taught by two seasoned value investors, Amit Kumar, and Nishant Gupta. I am deeply grateful to these exceptional professors for their guidance and expertise.</p><ul><li><strong>Reflect:</strong></li></ul><p>I have gained a great deal from this course, including developing an investment idea using the Blue Ridge Investment Template, strategies for long and short investments, core principles of value investing, and insights into market trends. It’s an intensely practical course, with weekly assignments that we later discuss and present in each class.</p><p>Before this course, I had already been engaged in fundamental investing for five years and had read several classic books, such as <em>The Most Important Thing Illuminated: Uncommon Sense for the Thoughtful Investor</em>, <em>Poor Charlie’s Almanack: The Wit &amp; Wisdom of Charlie Munger</em>, and <em>A Random Walk Down Wall Street</em>. While these books offer valuable concepts, I often found them somewhat superficial or overly general. This made me think that a structured, formal course in value investing could deepen my understanding. <strong>After completing this course, I’ve come to see that the most challenging aspect of investing is that only about 1% of the effort is about understanding the principles, while the remaining 99% lies in consistently applying those principles.</strong></p><blockquote><strong>“A good investor should be a voracious learner.”</strong></blockquote><p>The content will be summarized into main 5 parts… (there are still other parts, and I couldn&#39;t cover them all in one article.)</p><ol><li><strong>Thinking like a business owner</strong></li><li><strong>Investment Criteria and Philosophy</strong></li><li><strong>Management Team Evaluation</strong></li><li><strong>“Buying Well” = Right + NON-Consensus</strong></li><li><strong>Blue Ridge Investment Template</strong></li></ol><p>So…</p><p>Let’s start it.</p><p>1. <strong>Thinking like a business owner: (how to grow the business…)</strong></p><blockquote><strong>ROIC = NOPAT / Invested Capital</strong></blockquote><p><strong>(</strong>*Invested Capital = Total Assets — Cash — NIBCLs)</p><p>ROIC is one of the most important factors to look at when investing. We can think of ROIC by viewing the DCF valuation model as below.</p><p><strong>DCF model: g = π + p × (ROIC — π); p = fraction of NOPAT</strong></p><p><strong>In the DCF model, the key assumption is “g”, the growth rate we assume. A higher ROIC can lead to higher projected future cash flows, thus increasing the intrinsic value. A company is thought to create value if its ROIC exceeds its weighted average cost of capital (WACC).</strong></p><p>We need to assess the percentage of NOPAT that companies reinvest and how effectively they can grow this reinvested capital. If a company can grow this capital efficiently — at a rate of around 30%, as TSMC has achieved — it could generate substantial returns if the investment plan performs as anticipated. Additionally, with TSMC’s Capex projected to be approximately 1.1 times its NOPAT, <strong>there is potential for TSMC to achieve a growth rate of around 40% in terms of intrinsic value</strong>, assuming these investments deliver the expected returns.</p><blockquote><strong>In other words, ROIC measures a company’s efficiency in allocating the capital under its control to profitable investments (Focusing on operating efficiency). A high and consistent ROIC indicates strong management, a competitive advantage, quality earnings, and sustainable growth potential, ROE only focus on Equity and exclude the effect from debt leverage.</strong></blockquote><p>Target Corp. (TGT) calculates its ROIC directly in its 10-K, showing the components that went into the calculation:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/841/1*G3IxFO6OL0cIuKCOaQ9g-A.png" /></figure><blockquote><strong>A very important point for long-term investors to discover…</strong></blockquote><blockquote><strong>Structurally moving out of ROIC quartiles = fundamental changes in the company’s business operations or market conditions.</strong></blockquote><p><strong>2. Investment Criteria and Philosophy:</strong></p><ul><li><strong>Warren Buffett’s 20-Slot Rule: </strong>advised thinking about investments as if you had a lifetime limit of only 20 investment opportunities.</li><li>Focus on long-term investments with a horizon of 5–10 years. If you couldn’t hold it for 10 years, not even thinking about buying it for 10 minutes.</li><li>Look for companies with <strong>durable qualities</strong> like scarcity, scale, and strong stewardship.</li></ul><p><strong>About screening and selection:</strong></p><ul><li>Emphasize ROIC and ROCE to assess capital efficiency and profitability.</li><li>Use quantitative and sector screening methods, Piotroski Score, insider trading, and paradigm shifts to find potential investments.</li><li><strong>Avoid new IPOs due to information disadvantages.</strong></li><li><strong>52-Week High</strong>: A 52-week high can signal structural changes within a company, reflecting improved fundamentals, competitive positioning, or market conditions.</li></ul><blockquote><strong>Concentration rule: Focus on identifying investment targets with at least a 50% upside potential from the current stock price over a 3- to 4-year horizon. Remember, high-quality investment opportunities are rare and valuable. Securing just 10 high-quality investments throughout a lifetime can yield significant returns and build a strong portfolio.</strong></blockquote><p><strong>3. Management Evaluation:</strong></p><blockquote>A good management team should focus on creating real, long-term value. <strong>From this point of view, the family business is an excellent example, because they tend to treat the business as a perpetual entity, ensuring its longevity.</strong></blockquote><p><strong>In contrast, non-family businesses may sometimes face conflicts of interest, particularly between management and shareholders. </strong>Managers might be incentivized to prioritize short-term gains to boost stock prices or meet quarterly targets, which can lead to decisions that are not in the best interest of the company’s long-term health.</p><blockquote><strong>3 main points to assess: the capability of the management team’s capital allocation, buyback decisions, and middle management strength.</strong></blockquote><p>For example, we could discuss about buyback issue.</p><p><strong>How should investors react to Buy Back?</strong></p><p>Next plc annual report from 2013 written by Simon Wolfson</p><blockquote><strong>“The only reason share buybacks can deliver long term value is because they permanently reduce the number of shares in issue and so increase the amount of profit attributable to each share (EPS).” by NEXT plc</strong></blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/777/1*8kfSdSItZI9ozp5lF0zlOw.png" /></figure><p>Efficient Capital Allocation: Value investors look for companies that allocate capital efficiently. A buyback can be a good use of excess cash, especially if there are limited opportunities for profitable reinvestment in the business.</p><p>The graph below illustrates the long-term correlation of share price to EPS for NEXT plc over the period we have been buying back shares.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/776/1*uvLavd6rRZL1XXSCGJOsrw.png" /></figure><p>An easy logic to think about is :</p><blockquote><strong>Buy Back -&gt; Number of Share Decreasing -&gt; EPS Rising -&gt; (If PE maintain) -&gt; Price will go up</strong></blockquote><p>The next question is, how is the return of the buyback decision?</p><p><strong>Step 1: Cash for buyback</strong></p><p><strong>Step 2: To compute how much the Number of Outstanding Shares will decrease based on the amount of buyback</strong></p><p><strong>Step 3: Computing new EPS, from NI / New Number of Outstanding Shares (Earning Enhancement)</strong></p><p>A real example is shown below…</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/531/1*liqjwxpEnoHHvAf4PRVOvw.png" /></figure><blockquote>However, important thing to remember is that the benefit of buyback will decrease!</blockquote><p>When the share price goes up, the smaller share of the business can be bought with the same amount of surplus cash.</p><p>In most cases, if the market does not react proportionally to the increase in EPS by increasing the share price to the same extent, the PE ratio will indeed lower.</p><blockquote>The overall effect is simple: <strong>as the PE ratio rises,</strong> the earnings enhancement of buybacks falls. <strong>(this means that buying back shares becomes more expensive because the company needs to spend more cash to repurchase each share.)</strong></blockquote><p><strong>4. “Buying Well” = Right + NON-Consensus</strong></p><blockquote><strong>Everyone in the market often says, “This stock has good growth potential, so you should buy it.” However, that’s not the right approach. The current price reflects the market’s expectations for the company. </strong>If you only know what the market already agrees on, you’ll earn “normal profit,” not alpha. Alpha comes from identifying non-consensus opportunities, where the market’s view differs from your own.</blockquote><p>For example, in the second half of 2021, most people believed the PC industry was in decline. However, I predicted a significant growth in PC demand due to the shift towards online teaching and remote work caused by COVID-19. This contrarian view led to a 50% profit from ASUS (2357-TPE) within three months as the market began to recognize the increased demand for PCs.</p><blockquote>During our course, we are recommended to use “Visible Alpha” to access consensus estimates for each stock, including 5 to 10 years of financial forecasts and valuations. <strong>To achieve alpha, you need not only to develop your own theory but also to understand the market’s perspective. Make sure that you are not the only idiot.</strong></blockquote><p><strong>5. Blue Ridge Investment Template</strong></p><p>Blue Ridge Investment Template is the investment evaluation report template used by UVA Value Investment Pitch Competition Sponsored by Blue Ridge Capital. We are asked to use this form during courses, which is good practice for illustrating your investment ideas, compared to market consensus.</p><p><strong>The structure:</strong></p><ul><li><strong>Investment Thesis</strong></li><li><strong>Misperception</strong></li><li><strong>Most Compelling VAR Point</strong></li><li><strong>How it Plays Out</strong></li><li><strong>Risks</strong></li><li><strong>Signposts</strong></li></ul><p>VAR point includes conversations with key individuals that will help understand opportunity.</p><blockquote><strong>Strong understanding of key valuation drivers -&gt; applied in Valuation &amp; Scenario Analysis.</strong></blockquote><p>Use a range of models including DCF, sum of parts, and other valuation frameworks to cross-verify investment decisions. Also, monitor structural ROIC inflection and quarterly changes in ROIC expectations.</p><blockquote><strong>Valuation Models are meaningless if you don’t understand the business model and company deeply enough (do not spend most of time on excel, instead of talking to key person)</strong></blockquote><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=603276640e63" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[《價值體悟 — 2024.6》]]></title>
            <link>https://medium.com/@Yi-Jung/before-trilogy-e3ca8175d297?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/e3ca8175d297</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Sat, 20 Jan 2024 00:10:40 GMT</pubDate>
            <atom:updated>2025-10-18T10:46:09.987Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*XXDwoujYtpLOuaiZrmx0FQ.jpeg" /></figure><p>Why I love this series so much, is not only about romantic love （a bit for sure）, but mor importantly, it is about searching the meaning of life.</p><blockquote><strong>We are stardust. / Past is Past.</strong></blockquote><p>Similar to the insights from the book I recently read, ‘I May Be Wrong,’ written by Björn Natthiko Lindeblad, where <strong>‘This too shall pass’</strong> is inscribed on his wedding ring, a powerful reminder resonates.</p><p><strong>In Buddhism, a central concept highlighted is “Impermanence”.</strong> It teaches that everything is transient, including both joy and suffering.</p><p><strong>Returning to the investment world, the principle of constant change is ever-present.</strong> Nothing remains static indefinitely, including the concept of ‘Value,’ as highlighted by Zheng Zei. This is precisely why the notion of a moat in today’s business landscape is not only static but dynamic. Google, despite being one of the largest corporations, continues to underscore the importance of innovation. Through initiatives like GV (Google Ventures), Google actively seeks and fosters new ideas, demonstrating a commitment to finding and creating value for the future.</p><blockquote><strong>Therefore, if everything will change, including love and feeling toward someone. Why should we marry and stay together just for a piece of paper? </strong>— This question has been occupying my thoughts for several months.</blockquote><p>Like, I can give myself enough mental support, take care of myself well, and relish my own company. Sometimes spending times with families and friends. Aren’t these components enough to constitute a fulfilling life?</p><p>However, I just felt finding an answer from Before Midnight.</p><blockquote><strong>Yes. Love is not a must, but rather an addition. Blooming only when someone has a life of their own.</strong></blockquote><p>There is a scene that Jesse and Celine sitting together, having lunches with several couples. One elderly man said that, “we are never just one person, but two. What’s important is not the love for one person, but the love for life itself.”</p><p>This responds to the earlier notion that <strong>for many people, being in a relationship is just about two people who don’t know how to be alone</strong>.</p><p>What does it mean to know how to be alone? It means having a love for one’s own life. When a person can continually create passion in their own life, they bring a positive and cyclical energy to a relationship. It’s when an individual’s life is fulfilling that a partnership can truly flourish. The “love” can truly last. Sharing and augmenting each other’s lives is what gives meaning to moving forward together —</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=e3ca8175d297" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[以VC角度看 — 新創大騙局 “The Dropout”]]></title>
            <link>https://medium.com/@Yi-Jung/%E4%BB%A5vc%E8%A7%92%E5%BA%A6%E7%9C%8B-%E6%96%B0%E5%89%B5%E5%A4%A7%E9%A8%99%E5%B1%80-the-dropout-78815225189b?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/78815225189b</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Mon, 06 Mar 2023 09:20:44 GMT</pubDate>
            <atom:updated>2023-04-16T08:29:40.763Z</atom:updated>
            <content:encoded><![CDATA[<h3>以風險投資角度分析影集《新創大騙局》</h3><blockquote><strong>1. 簡介</strong></blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*PJ6Cz3rrpAYJ8GrgPAUVZA.png" /></figure><ul><li>此影集以2003年創立的生技獨角獸 <strong><em>[1]</em></strong> — Theranos 為背景，描述一起引起矽谷與全球投資人轟人大波的詐騙案。</li><li>主角，伊莉莎白·荷姆斯 (Elizabeth Holmes)，Theranos的創辦人，具備了耳熟能詳、成功創業家的所有特質: <strong><em>年輕、史丹佛大學、顛覆產業的新技術。</em></strong></li></ul><blockquote><strong>「一滴血，即可進行一系列醫療檢測。」</strong></blockquote><p>過去，為了進行檢測，民眾必須前往醫院進行靜脈抽取，取得約10至20毫升的血液樣本。然而，對許多人來說，這是一個讓他們感到害怕的過程；因此Theranos公司提出的解決方案非常簡單：只需要一根針，刺破手指後，一滴血就可以完全取代傳統的抽血流程。這樣不僅使得抽血變得更加便宜和快速，也使民眾更容易取得自己的生理資料，進一步顛覆整個檢測產業。</p><p><strong>以下將以募資階段依序介紹Theranos的過往發展，說明這家被譽為將改變世界的生技巨頭如何一步步走向滅亡。</strong></p><ul><li><strong>2003年~2004年 (Series Seed)<em> [2]</em> :</strong></li></ul><p>起初，荷姆斯有著很優秀的理念，她曾向幾位史丹佛大學的教授詢問，並提交了她的計畫書。最終，她找到了工程學院院長錢寧·勞勃遜（Channing Robertson），並成功說服他成為公司的第一位董事。</p><ul><li><strong>2004年~2006年 (Series A ~ Series C) <em>[2]</em> :</strong></li></ul><p>擴張期，由於公司研發資金迅速消耗，急需引入外部投資人，荷姆斯積極找尋風投 <strong><em>[3]</em></strong><em> </em>入資，投資人包含Rupert Murdoch (FOX董事長)、ATA Ventures、Donald Lucas (Lucas Venture Group)，而在一次Pitch的前晚，Prototype突然故障，為了成功說服投資人入股，荷姆斯決定在Pitch中動手腳。(Fake it till you make it)</p><ul><li><strong>2007年~2009年 (Venture Round) <em>[2]</em> :</strong></li></ul><p>由於創投入股後，要求公司快速上架產品，然而荷姆斯未能如期達成目標。因此，董事會決定撤換荷姆斯。但荷姆斯為了保住自己的職位，於2009年說服男友桑尼·巴爾瓦尼（Sunny Balwani）注資2000萬美元後，雙方持股超過了51%。</p><ul><li><strong>2009 ~ 2017年 <em>[2]</em> :</strong></li></ul><p>桑尼·巴爾瓦尼加入之後，由於原始開發的技術尚不成熟，荷姆斯決定放棄原始產品的開發，並解雇了原先負責人顧愛德蒙（Edmond Ku），改而聘請了新的團隊，獨立開發新的儀器「愛迪生（Edison）」。但實際上，愛迪生只能做不到 20 種免疫測定，因此荷姆斯向德國西門子（Siemens）購買了大量現成的驗血儀器，但幾滴血對於這些儀器來說並不足以進行測試，荷姆斯因此大量稀釋血液<strong><em>[4]</em></strong>，以此進行檢測。從那時起，Theranos就一步步走向崩潰。</p><p><strong><em>[註1] </em></strong><em>獨角獸 (Unicorn)是指成立不到10年，但估值10億美元（$1 billion）以上，又未在股票市場上市的科技創業公司。</em></p><p><strong><em>[註2]</em></strong><em> 募資紀錄皆來自Crunchbase</em></p><p><strong><em>[註3]</em></strong><em> 風險投資 Venture Capital; 台灣又稱創業投資。</em></p><p><strong><em>[註4] </em></strong><em>The Wall Street Journal 於2015年便指出Theranos在所有血液檢測中所用的並非自身開發的技術，且指出Edison實際上只能執行12項檢測。 (</em><a href="https://www.wsj.com/articles/theranos-has-struggled-with-blood-tests-1444881901#pq=Jd8MoW"><em>https://www.wsj.com/articles/theranos-has-struggled-with-blood-tests-1444881901#pq=Jd8MoW</em></a><em>; </em><a href="https://arstechnica.com/tech-policy/2021/11/holmes-claimed-theranos-could-do-more-than-1000-tests-it-did-12/)"><em>https://arstechnica.com/tech-policy/2021/11/holmes-claimed-theranos-could-do-more-than-1000-tests-it-did-12/)</em></a></p><blockquote><strong>2. 以VC角度看 Theranos</strong></blockquote><p><strong>一、創始團隊的離開是一大風險警示:</strong></p><p>Theranos的創始成員之一，首席科學家伊恩吉本斯（Ian Gibbons）具有深厚的學術背景。他是劍橋大學化工系博士，從事診斷和治療產品的研究長達30年，並擁有近200個專利。然而，他日以繼夜地工作仍無法跟上Theranos創始人伊莉莎白·荷姆斯的誇大故事，荷姆斯最終取消了吉本斯的職位，而專利糾紛也讓吉本斯於2013年自殺。</p><p>而筆者認為，從VC的角度來看，特別是在生技公司，重點在於公司的科研能力，首席科學家代表了公司的深度和實力。因此，在盡職調查中，需要特別關注首席科學家的背景和能力；此外，在投資前，由於存在外部和內部人士之間的資訊落差，對公司進行充分的調查是非常必要的。針對Theranos案例，調查重點應該集中在吉本斯離開公司的原因、新的團隊是否具有持續發展技術的能力、專利糾紛以及調查吉本斯和團隊過去的背景等多個方面，這樣才能確保投資的可靠性和公司的長期發展。</p><p><strong><em>Not the right team &amp; disharmony among team are the two main reasons for startups fail — CB Insights</em></strong></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/616/1*xh1KAl0f-gJa2y5t5Y7nyQ.png" /><figcaption>Top reasons why startups fail — CB Insights</figcaption></figure><p>筆者相信，對於前期投資人而言，評估Theranos時，絕對不是因為一個很好的故事以及想法即投資，主要原因還是取決於團隊背景，伊恩吉本斯與董事錢寧教授將是早期投資人相信這家新創的關鍵，畢竟要成功利用一滴血液進行檢測(約為傳統抽血量的1/100~1/1000)，必定會面臨巨大的技術瓶頸，而伊恩與錢寧教授在Biotrack的專利 <strong><em>[註5] </em></strong>為投資人相信技術突破口的重點。</p><p><strong><em>“I never figured out from the [Theranos] patents how they were claiming to do the assays,” — Norman A. Paradis, a professor of medicine at Dartmouth College, who specializes in biomedical devices, tells Refinery29 via email.</em></strong></p><p><strong><em>[註5]</em></strong><em> </em>伊恩與錢寧教授在Biotrack的專利: <a href="https://patents.google.com/patent/US4946795A/en">US4946795A — Apparatus and method for dilution and mixing of liquid samples — Google Patents</a></p><p><strong>二、盡職調查是否確實:</strong></p><p>在Walgreens在評估合作時，曾找了具生技背景的產業專家來進行Technical Due Diligence，然而創辦人荷姆斯以技術保密與競爭為由，不允許Walgreens查看他們的實驗室，甚至不解釋技術運作的原理，在此情況下，Walgreens原不應簽下合作條約，但由於Walgreens當時極需開拓新的營收線，且荷姆斯持續提及其與CVS藥局的潛在合作，因此Walgreens在壓力下未徹底對技術面執行盡職調查而簽下了140億美元的合約，而在獲得與Walgreens的合約後，荷姆斯可再繼續向潛在投資人宣稱其已經通過Walgreens的審核，成功進入上市階段，進而減低潛在投資人的疑慮。</p><p>而從此次事件來看，投資人如進行確實的盡職調查其實是可以避免此次的損失的，如Bill Maris，Google Ventures的創辦人曾提及，他們當時拒絕投資Theranos，即是因為他們前往Walgreens做盡職調查時，看到現場的產品demo發現了些不尋常，且Theranos對其技術的透明度不足 <strong><em>[註6]</em></strong>。</p><p><strong>“We looked at it a couple times, but there was so much hand-waving — like,<em> Look over here!</em> — that we couldn’t figure it out,” — — Bill Maris, the Founder of Google Venture.</strong></p><p><strong><em>[註6] </em></strong><a href="https://www.businessinsider.com/bill-maris-explains-why-gv-didnt-invest-in-theranos-2015-10">Maris: Why GV Didn’t Invest in Theranos (businessinsider.com)</a></p><p><strong>三、董事會的組成:</strong></p><p>前述所提，VC在評估新創投資時，非常重視董事會成員的背景和能力，因為董事會是公司最高層的管理機構，具有最大的實際管理權，對於新創公司而言，董事會的作用尤為重要。良好的董事會成員可以掌握公司內部的情況，協助公司籌措資源，提供自身的產業經驗和人脈，並在第一時間協助公司成長和步上正軌。因此，VC在投資時會特別關注董事會成員的背景和能力，確保他們能夠對公司的發展做出積極貢獻。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/842/1*GhWlbVcKyIq51FkpeHnA1A.png" /><figcaption>Board Members of Theranos</figcaption></figure><p>然而，Theranos的董事會組成卻令人感到疑惑，總共12員董事，除CEO荷姆斯與COO桑尼，多達7員來自軍事與政府部門，包含前美國國防部長、國務卿等，看起來光鮮亮麗，但皆不是來自生技相關背景，而另外3員董事中，甚至只有William Foege其背景與生技相關，然而董事會是投資人第一手的把關，這樣的董事會有足夠的能力監督執行團隊嗎?</p><p>而在另一方面，創投評估投資案時，也非常重視董事成員是否有足夠能力協助公司成長，這樣的背景對一家生技新創而言，恐怕宣傳效果大於實質作用；而除此之外，COO桑尼·巴爾瓦尼(Sunny Balwani)甚至沒有任何生技相關的工作背景，這都不禁使外部人對公司成員的組成打了一個很大的問號。</p><p><strong>“When GV is looking at life-science companies, it wants to invest in startups that <em>are open about their technology</em> and have a board with a lot of tech expertise.” — Bill Maris, the Founder of Google Venture.</strong></p><blockquote><strong>3. 結語</strong></blockquote><p>總結而言，當時許多頂級 VC 拒絕投資 Theranos 的原因，即是因為該公司持續聲稱出於知識產權方面的考慮，拒絕分享其技術或結果準確的證據。身為投資人，應在短時間內迅速了解DD的重點為何， Financial DD、Legal DD、IP DD 等；而對於投資人，如何在緊湊的募資期間，集中資源與時間在對的地方為關鍵，這取決於各階段、各投資案皆不相同，如在過去評估一家SaaS公司時，筆者放大部分時間在對該公司執行Financial 與Legal DD，主要原因為該公司的收入高於50%集中前三大客戶，需要了解未來新客戶的導入方式以及原有客戶是否穩定。</p><p>而除此之外，在過往工作經驗中，曾有一家硬體廠商看似非常有潛力，但對於該公司的關鍵技術突破點，始終找不到適合的產業專家作評估驗證，因此最後沒有投資該新創，這就是做為投資人非常重要的地方，失敗的投資比錯失投資嚴重許多，投資人只有在做出錯誤投資才會收到真正的懲罰，在波克夏海瑟威一九九七年的年報中，巴菲特就曾談到一名打擊手，「閃耀瘦皮猴」(Splendid Splinter) 的Ted Williams，造就他成功的一個關鍵因素即是他對自己的比賽有深入研究，他將球區分成七十七個棒球大小的方格，他深知自己的打擊「甜蜜點」，在球落入「甜蜜點」在揮棒可以大大提高擊球率，<strong>而作為風投同樣應該如此，我們承受風險，但我們只承受應有的「風險」，不完全的盡職調查將會使自己落在高危險處</strong>，平時應多累積不同產業的專家人脈並持續吸收知識，逐漸生成並強化自己的投資「甜蜜點」。</p><blockquote><strong>... Some fun fact</strong></blockquote><p>一家以色列新創公司 Sight Diagnostics 正在進行類似於Theranos的業務，但他們強調與Theranos不同的地方在於，他們的OLO分析儀已在2019年通過了FDA的510(k)批准，確認其全血細胞計數（CBC; Complete blood count）的準確性與標準實驗室等級的系統相當。CBC是醫學領域中最為常見的血液檢測項目之一，常用來檢查病人紅血球、白血球、血小板等資訊，如透過WBC白血球計數，可判斷是否有細菌感染的情況。</p><p>相比之下，Theranos在其技術未經過任何獨立驗證之前就將產品商業化並宣稱其設備可準確地進行數十種血液測試，且還強調了其技術的保密性，並拒絕分享技術或準確的證據，這些因素最終促使了Theranos的崩潰和涉及多項法律訴訟。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/868/1*eMjxTF6st6wQCTTBpUjBlw.png" /></figure><p>OLO分析儀的儀器體積小於傳統測試設備許多，且只需兩滴血液放置在如明信片般大小的一次性試劑盒，相較傳統上需抽取約3ml的血液，大幅減低了使用上所需的空間。</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/877/1*HI86BbDnIT39Dp1pVdXXJA.png" /></figure><p>而Sight Diagnostics自2011年成立以來，已籌集1.24億美元，將透過D輪融資推動OLO分析儀的商業化。</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=78815225189b" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[2022 開發資本儲備幹部 面試分享]]></title>
            <link>https://medium.com/@Yi-Jung/2022-%E9%96%8B%E7%99%BC%E8%B3%87%E6%9C%AC%E5%84%B2%E5%82%99%E5%B9%B9%E9%83%A8-%E9%9D%A2%E8%A9%A6%E5%88%86%E4%BA%AB-91c2b6f48ad3?source=rss-131691031a66------2</link>
            <guid isPermaLink="false">https://medium.com/p/91c2b6f48ad3</guid>
            <dc:creator><![CDATA[D]]></dc:creator>
            <pubDate>Fri, 17 Jun 2022 14:04:02 GMT</pubDate>
            <atom:updated>2022-06-17T14:18:42.910Z</atom:updated>
            <content:encoded><![CDATA[<p>想趁著畢業前夕，來整理一下這次儲備幹部的面試經驗。</p><p>先講流程，總共分為四個階段:</p><ul><li>投遞履歷 + 不超過3分鐘的自我介紹影片 (2021/11初)</li><li>First round interview (2021/12 月初)</li><li>Social event (2021/12 月中)</li><li>Final round interview (2022/1 月中)</li></ul><p>而筆者最終進入Final round，但不幸地未被選上，但一路上受到許多前輩幫助，所以希望這篇文能夠幫助未來的夥伴。</p><p>開發資本大概是最早開始的儲備幹部，大約落在2021年11月須繳交履歷，履歷的部分需使用開發金控制式的履歷，共6面 (3面 / 中英文)，內容除基本CV內容外，也包含了領導經驗的描述、分析個人競爭力、經濟議題的分析等等，最後外加一頁式的自傳，整體撰寫需花費2–3天，有意申請的人需留意；另外在影片的部分，為了追求完美，也重複錄很多次，當初錄了一整晚，所以也須注意。</p><p>-First round interview:</p><p>面試官有四位，一位人資 + 資本投資部三位 (副總、兩位協理)，進行一對四的20分鐘面試，包含自我介紹+研究專題分享+主管QA，研究專題為當場抽籤，30分鐘找資料加PPT製作，非常緊湊，我抽到的簡報題目為描述台灣電動車的優劣勢，基本上平時要對各產業有基本認知，找資料要準確，不能浪費任何時間在找沒辦法用的資料，或是硬放上簡報，會讓整體邏輯看起來很鬆散，而QA部分，我當時的主管有對報告內容問了3~4題，接著主要都是詢問CV，但同組的人也有被問很多報告內容，所以僅供參考；而結束個人面試後，會進行50分鐘的四對四集體面試，主要是偏向Softskill的QA，主要為中文回答，但穿插英文題2~3題。</p><p>-Social Event:</p><p>全英文的介紹會，會有各子公司的高階經理與進入面試的候選人近距離的QA。</p><p>-Final round interview:</p><p>面試官5~6位(人資 + 資本各副總)，Case study，5人一組，40分鐘討論，10分鐘報告&amp;40分鐘QA，當時抽到的題目為睿生光電，須對該公司做投資分析，基本上就是一個完整標的分析，需要的能力就是平常就能對個股清晰地分析。團體QA包含此案投資風險、處理投資案業務會面臨競價時如何面對、19年成立後成長速度為何如此快速。</p><p>結論 &amp; 心得分享:</p><p>整體來說，我很喜歡開發資本的面試，First round interview的簡報關，能夠表現出面試者資料蒐集的能力、邏輯的整理，QA與主管對談的氛圍很好；Social event很用心，能更了解公司的業務內容；Final round interview，基本上就是考驗做為一個投資經理的基本能力，需在短時間內了解一家企業，並在內部報告，說服自身公司投資此案，將所有可能被問的問題準備好。</p><p>在面試開發資本的過程中，雖然最後得知結果不盡人意時，失落了好一陣子，但整體來說，這個過程使我更加了解創投產業，而也在這之後有幸到了外商創投，至今，我依舊深深迷戀這個產業，願這篇貼文能幫助到所有想往創投發展的人。</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=91c2b6f48ad3" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>